Craveiro V - Search Results

1

Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells.

Alvero AB, Montagna MK, Holmberg JC, Craveiro V, Brown D, Mor G. Alvero AB, et al. Among authors: craveiro v. Mol Cancer Ther. 2011 Aug;10(8):1385-93. doi: 10.1158/1535-7163.MCT-11-0023. Epub 2011 Jun 15. Mol Cancer Ther. 2011. PMID: 21677151 Free PMC article.

2

Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential.

Yin G, Alvero AB, Craveiro V, Holmberg JC, Fu HH, Montagna MK, Yang Y, Chefetz-Menaker I, Nuti S, Rossi M, Silasi DA, Rutherford T, Mor G. Yin G, et al. Among authors: craveiro v. Oncogene. 2013 Jan 3;32(1):39-49. doi: 10.1038/onc.2012.33. Epub 2012 Feb 20. Oncogene. 2013. PMID: 22349827 Free PMC article.

3

Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype.

Alvero AB, Montagna MK, Craveiro V, Liu L, Mor G. Alvero AB, et al. Among authors: craveiro v. Am J Reprod Immunol. 2012 Mar;67(3):256-65. doi: 10.1111/j.1600-0897.2011.01068.x. Epub 2011 Sep 14. Am J Reprod Immunol. 2012. PMID: 21917055 Free PMC article.

4

TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.

Chefetz I, Alvero AB, Holmberg JC, Lebowitz N, Craveiro V, Yang-Hartwich Y, Yin G, Squillace L, Gurrea Soteras M, Aldo P, Mor G. Chefetz I, et al. Among authors: craveiro v. Cell Cycle. 2013 Feb 1;12(3):511-21. doi: 10.4161/cc.23406. Epub 2013 Jan 16. Cell Cycle. 2013. PMID: 23324344 Free PMC article.

5

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.

Craveiro V, Yang-Hartwich Y, Holmberg JC, Joo WD, Sumi NJ, Pizzonia J, Griffin B, Gill SK, Silasi DA, Azodi M, Rutherford T, Alvero AB, Mor G. Craveiro V, et al. Cancer Med. 2013 Dec;2(6):751-62. doi: 10.1002/cam4.115. Epub 2013 Aug 27. Cancer Med. 2013. PMID: 24403249 Free PMC article.

6

Ovulation and extra-ovarian origin of ovarian cancer.

Yang-Hartwich Y, Gurrea-Soteras M, Sumi N, Joo WD, Holmberg JC, Craveiro V, Alvero AB, Mor G. Yang-Hartwich Y, et al. Among authors: craveiro v. Sci Rep. 2014 Aug 19;4:6116. doi: 10.1038/srep06116. Sci Rep. 2014. PMID: 25135607 Free PMC article.

7

Murine model for non-invasive imaging to detect and monitor ovarian cancer recurrence.

Sumi NJ, Lima E, Pizzonia J, Orton SP, Craveiro V, Joo W, Holmberg JC, Gurrea M, Yang-Hartwich Y, Alvero A, Mor G. Sumi NJ, et al. Among authors: craveiro v. J Vis Exp. 2014 Nov 2;(93):e51815. doi: 10.3791/51815. J Vis Exp. 2014. PMID: 25407815 Free PMC article.

8

p53 protein aggregation promotes platinum resistance in ovarian cancer.

Yang-Hartwich Y, Soteras MG, Lin ZP, Holmberg J, Sumi N, Craveiro V, Liang M, Romanoff E, Bingham J, Garofalo F, Alvero A, Mor G. Yang-Hartwich Y, et al. Among authors: craveiro v. Oncogene. 2015 Jul;34(27):3605-16. doi: 10.1038/onc.2014.296. Epub 2014 Sep 29. Oncogene. 2015. PMID: 25263447

9

Effect of culture conditions on the phenotype of THP-1 monocyte cell line.

Aldo PB, Craveiro V, Guller S, Mor G. Aldo PB, et al. Among authors: craveiro v. Am J Reprod Immunol. 2013 Jul;70(1):80-6. doi: 10.1111/aji.12129. Epub 2013 Apr 29. Am J Reprod Immunol. 2013. PMID: 23621670 Free PMC article.

10

White blood cells in a healthy adolescent population according to social and health characteristics.

Barroso I, Ramos E, Craveiro V, Guimarães JT. Barroso I, et al. Among authors: craveiro v. Arch Pediatr. 2023 Aug;30(6):361-365. doi: 10.1016/j.arcped.2023.03.008. Epub 2023 May 4. Arch Pediatr. 2023. PMID: 37147155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page